Autres langues Sanofi OTC Markets

Actions

SNYNF

FR0000120578

Marché Fermé - OTC Markets Autres places de cotation 19:02:55 26/06/2024			Varia. 5j.	Varia. 1 janv.
95,5 ^USD	-0,52%		+3,19%	-4,13%

27/06	CAC40 : la prudence l'emporte avant des échéances cruciales	CF
27/06	CAC40 : consolide en solo, 'spread' OAT/Bund se creuse à 81Pb	CF

Autres langues

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

CAC40 : la prudence l'emporte avant des échéances cruciales	27/06
CAC40 : consolide en solo, 'spread' OAT/Bund se creuse à 81Pb	27/06
Wall Street Set to Open Marginally Lower Thursday as Investors Parse Bullish Economic Data	27/06
Sanofi - Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM	27/06
US Futures Trend Lower Pre-Bell as Investors Await Slew of Economic Data	27/06
Top Premarket Gainers	27/06
Vigil Neuroscience Shares Soar on $40 Million Sanofi Investment	27/06
Regeneron, Sanofi Eosinophilic Esophagitis Treatment Showed Improvements for Children in Phase 3 Study	27/06
CAC40 : sous les 7600 pts, freiné par le secteur auto	27/06
Vigil Neuroscience Receives $40 Million Investment From Sanofi	27/06
The same old winners	27/06
Borsa di Italia: I soliti vincitori	27/06
Bolsa de Madrid: Los mismos ganadores de siempre	27/06
Sanofi : publication positive pour Dupixent dans le NEJM	27/06
Sanofi Partakes in Formation Bio's $372 Million Fundraising	27/06
Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM	26/06
Regeneron Pharmaceuticals, Inc Announces Dupixent® Positive Phase 3 Data in Children 1 to 11 Years of Age with Eosinophilic Esophagitis Published in the New England Journal of Medicine	26/06
FDA approves Verona Pharma's therapy for 'smoker's lungs'	26/06
Sanofi-backed Drug Developer Formation Bio Raises $372 Million	26/06
Sanofi-backed Formation Bio raises $372 million in late-stage funding round	26/06